US Stock MarketDetailed Quotes

MEDIF MEDIPHARM LABS CORP

Watchlist

0.049455
-0.001145-2.26%

15min DelayClose Aug 5 16:00 ET

20.02MMarket Cap-1705P/E (TTM)

MEDIPHARM LABS CORP Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

49.98%-1.53M

23.21%-12.34M

977.38%1.47M

-11.95%-3.23M

-1.59%-7.53M

45.54%-3.05M

-21.62%-16.07M

95.85%-168K

-1,088.07%-2.89M

-151.25%-7.41M

Net income from continuing operations

-16.94%-3.61M

56.37%-13.08M

47.14%-2.97M

45.44%-4.33M

69.92%-2.7M

58.59%-3.09M

45.29%-29.98M

74.23%-5.61M

-7.82%-7.93M

23.92%-8.99M

Operating gains losses

-6,480.00%-319K

-70.47%269K

-100.91%-10K

103.16%38K

-82.28%236K

101.58%5K

131.31%911K

540.56%1.1M

-1,680.26%-1.2M

357.73%1.33M

Depreciation and amortization

61.22%790K

-12.40%2.52M

32.78%717K

-18.17%617K

-8.83%692K

-40.17%490K

-49.01%2.87M

-77.34%540K

-15.66%754K

-48.72%759K

Other non cash items

73.06%-66K

-1,420.70%-7.35M

-835.29%-2.23M

1,018.10%1.07M

-7,142.68%-5.94M

-421.28%-245K

-104.70%-483K

4.03%-238K

-134.94%-116K

-115.62%-82K

Change In working capital

-9.90%528K

-44.70%3.45M

31.34%5.17M

-142.64%-1.36M

37.98%-952K

-11.08%586K

-1.83%6.24M

65.49%3.94M

-27.41%3.18M

-1,548.11%-1.54M

-Change in receivables

-2,700.00%-616K

77.74%6.42M

318.87%5.77M

-314.95%-230K

1,204.35%900K

-101.07%-22K

-64.55%3.61M

-79.71%1.38M

-97.14%107K

103.11%69K

-Change in inventory

-106.68%-80K

3,123.30%3.11M

88.96%2.23M

-122.78%-416K

104.83%106K

231.50%1.2M

-104.14%-103K

18.75%1.18M

247.50%1.83M

-146.28%-2.2M

-Change in payables and accrued expense

336.68%1.88M

-446.48%-5.17M

-269.80%-1.27M

-439.27%-1.2M

-535.70%-1.9M

-1,668.89%-796K

118.39%1.49M

119.99%745K

111.83%354K

-62.93%437K

-Change in other current assets

59.00%159K

-160.89%-1.07M

-291.93%-1.38M

-30.61%807K

-54.15%-595K

-61.24%100K

152.01%1.75M

3.30%719K

--1.16M

---386K

-Change in other current liabilities

----

129.13%150K

-119.28%-182K

-15.81%-315K

----

-147.12%-515K

-126.95%-83K

-282.55%-272K

-21.02%541K

-Change in other working capital

-872.64%-819K

----

--106K

----

Cash from discontinued investing activities

Operating cash flow

49.98%-1.53M

23.21%-12.34M

977.38%1.47M

-11.95%-3.23M

-1.59%-7.53M

45.54%-3.05M

-21.62%-16.07M

95.85%-168K

-1,088.07%-2.89M

-151.25%-7.41M

Investing cash flow

Cash flow from continuing investing activities

2,200.00%525K

33.23%6.87M

-24.49%4.31M

619.94%1.64M

1,187.36%946K

82.64%-25K

14,637.14%5.16M

1,937.50%5.71M

-834.88%-316K

34.09%-87K

Capital expenditure reported

16.00%-21K

45.42%-471K

61.49%-119K

17.72%-260K

28.72%-67K

82.64%-25K

-10.22%-863K

-50.00%-309K

-174.78%-316K

48.91%-94K

Net PPE purchase and sale

--326K

--178K

-24,542.86%-1.73M

--1.9M

--0

66.67%-7K

--0

----

Net business purchase and sale

----

-12.50%5.26M

-29.35%4.25M

--0

----

--6.01M

--0

----

Net other investing changes

--220K

27,085.71%1.9M

----

-98.62%7K

----

Cash from discontinued investing activities

Investing cash flow

2,200.00%525K

33.23%6.87M

-24.49%4.31M

619.94%1.64M

1,187.36%946K

82.64%-25K

14,637.14%5.16M

1,937.50%5.71M

-834.88%-316K

34.09%-87K

Financing cash flow

Cash flow from continuing financing activities

92.82%-66K

-146.23%-368K

39.60%-241K

-109.09%-299K

-19.30%1.09M

-6,464.29%-919K

-97.14%796K

-40,000.00%-399K

76.17%-143K

3,855.56%1.35M

Net issuance payments of debt

76.91%-269K

-340.20%-944K

27.32%-391K

-40.07%-388K

-21.26%1M

-1,779.03%-1.17M

113.27%393K

-564.20%-538K

-241.98%-277K

1,793.33%1.27M

Cash dividends paid

--0

Net other financing activities

-10.40%224K

95.80%840K

37.58%227K

31.82%174K

125.00%189K

420.83%250K

408.63%429K

75.53%165K

140.12%132K

115.38%84K

Cash from discontinued financing activities

Financing cash flow

92.82%-66K

-146.23%-368K

39.60%-241K

-109.09%-299K

-19.30%1.09M

-6,464.29%-919K

-97.14%796K

-40,000.00%-399K

76.17%-143K

3,855.56%1.35M

Net cash flow

Beginning cash position

-25.53%17.98M

-29.21%24.15M

-33.43%12.95M

-32.97%14.74M

-28.73%20.15M

-29.21%24.15M

71.30%34.11M

-48.75%19.45M

-43.25%21.99M

-32.88%28.27M

Current changes in cash

73.29%-1.07M

42.31%-5.84M

7.84%5.54M

43.57%-1.89M

10.64%-5.49M

30.64%-4M

-169.16%-10.12M

236.50%5.14M

-318.25%-3.35M

-97.15%-6.15M

Effect of exchange rate changes

--12K

-319.33%-329K

-14.09%-510K

-88.12%96K

163.43%85K

--0

134.97%150K

-432.14%-447K

11,442.86%808K

47.45%-134K

End cash Position

-16.00%16.93M

-25.53%17.98M

-33.43%12.95M

-32.97%14.74M

-28.73%20.15M

-29.21%24.15M

-48.75%19.45M

-43.25%21.99M

Free cash flow

49.71%-1.55M

24.34%-12.81M

384.07%1.36M

-9.02%-3.49M

-1.21%-7.6M

46.47%-3.08M

-20.98%-16.93M

88.78%-477K

-794.69%-3.2M

-139.50%-7.51M

Currency Unit

CAD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	49.98%-1.53M	23.21%-12.34M	977.38%1.47M	-11.95%-3.23M	-1.59%-7.53M	45.54%-3.05M	-21.62%-16.07M	95.85%-168K	-1,088.07%-2.89M	-151.25%-7.41M
Net income from continuing operations	-16.94%-3.61M	56.37%-13.08M	47.14%-2.97M	45.44%-4.33M	69.92%-2.7M	58.59%-3.09M	45.29%-29.98M	74.23%-5.61M	-7.82%-7.93M	23.92%-8.99M
Operating gains losses	-6,480.00%-319K	-70.47%269K	-100.91%-10K	103.16%38K	-82.28%236K	101.58%5K	131.31%911K	540.56%1.1M	-1,680.26%-1.2M	357.73%1.33M
Depreciation and amortization	61.22%790K	-12.40%2.52M	32.78%717K	-18.17%617K	-8.83%692K	-40.17%490K	-49.01%2.87M	-77.34%540K	-15.66%754K	-48.72%759K
Other non cash items	73.06%-66K	-1,420.70%-7.35M	-835.29%-2.23M	1,018.10%1.07M	-7,142.68%-5.94M	-421.28%-245K	-104.70%-483K	4.03%-238K	-134.94%-116K	-115.62%-82K
Change In working capital	-9.90%528K	-44.70%3.45M	31.34%5.17M	-142.64%-1.36M	37.98%-952K	-11.08%586K	-1.83%6.24M	65.49%3.94M	-27.41%3.18M	-1,548.11%-1.54M
-Change in receivables	-2,700.00%-616K	77.74%6.42M	318.87%5.77M	-314.95%-230K	1,204.35%900K	-101.07%-22K	-64.55%3.61M	-79.71%1.38M	-97.14%107K	103.11%69K
-Change in inventory	-106.68%-80K	3,123.30%3.11M	88.96%2.23M	-122.78%-416K	104.83%106K	231.50%1.2M	-104.14%-103K	18.75%1.18M	247.50%1.83M	-146.28%-2.2M
-Change in payables and accrued expense	336.68%1.88M	-446.48%-5.17M	-269.80%-1.27M	-439.27%-1.2M	-535.70%-1.9M	-1,668.89%-796K	118.39%1.49M	119.99%745K	111.83%354K	-62.93%437K
-Change in other current assets	59.00%159K	-160.89%-1.07M	-291.93%-1.38M	-30.61%807K	-54.15%-595K	-61.24%100K	152.01%1.75M	3.30%719K	--1.16M	---386K
-Change in other current liabilities	----	129.13%150K	-119.28%-182K	-15.81%-315K	----	----	-147.12%-515K	-126.95%-83K	-282.55%-272K	-21.02%541K
-Change in other working capital	-872.64%-819K	----	----	----	----	--106K	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	49.98%-1.53M	23.21%-12.34M	977.38%1.47M	-11.95%-3.23M	-1.59%-7.53M	45.54%-3.05M	-21.62%-16.07M	95.85%-168K	-1,088.07%-2.89M	-151.25%-7.41M
Investing cash flow
Cash flow from continuing investing activities	2,200.00%525K	33.23%6.87M	-24.49%4.31M	619.94%1.64M	1,187.36%946K	82.64%-25K	14,637.14%5.16M	1,937.50%5.71M	-834.88%-316K	34.09%-87K
Capital expenditure reported	16.00%-21K	45.42%-471K	61.49%-119K	17.72%-260K	28.72%-67K	82.64%-25K	-10.22%-863K	-50.00%-309K	-174.78%-316K	48.91%-94K
Net PPE purchase and sale	--326K	--178K	-24,542.86%-1.73M	--1.9M	--0	--0	--0	66.67%-7K	--0	----
Net business purchase and sale	----	-12.50%5.26M	-29.35%4.25M	--0	----	----	--6.01M	--6.01M	--0	----
Net other investing changes	--220K	27,085.71%1.9M	----	----	----	----	-98.62%7K	----	----	----
Cash from discontinued investing activities
Investing cash flow	2,200.00%525K	33.23%6.87M	-24.49%4.31M	619.94%1.64M	1,187.36%946K	82.64%-25K	14,637.14%5.16M	1,937.50%5.71M	-834.88%-316K	34.09%-87K
Financing cash flow
Cash flow from continuing financing activities	92.82%-66K	-146.23%-368K	39.60%-241K	-109.09%-299K	-19.30%1.09M	-6,464.29%-919K	-97.14%796K	-40,000.00%-399K	76.17%-143K	3,855.56%1.35M
Net issuance payments of debt	76.91%-269K	-340.20%-944K	27.32%-391K	-40.07%-388K	-21.26%1M	-1,779.03%-1.17M	113.27%393K	-564.20%-538K	-241.98%-277K	1,793.33%1.27M
Cash dividends paid	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Net other financing activities	-10.40%224K	95.80%840K	37.58%227K	31.82%174K	125.00%189K	420.83%250K	408.63%429K	75.53%165K	140.12%132K	115.38%84K
Cash from discontinued financing activities
Financing cash flow	92.82%-66K	-146.23%-368K	39.60%-241K	-109.09%-299K	-19.30%1.09M	-6,464.29%-919K	-97.14%796K	-40,000.00%-399K	76.17%-143K	3,855.56%1.35M
Net cash flow
Beginning cash position	-25.53%17.98M	-29.21%24.15M	-33.43%12.95M	-32.97%14.74M	-28.73%20.15M	-29.21%24.15M	71.30%34.11M	-48.75%19.45M	-43.25%21.99M	-32.88%28.27M
Current changes in cash	73.29%-1.07M	42.31%-5.84M	7.84%5.54M	43.57%-1.89M	10.64%-5.49M	30.64%-4M	-169.16%-10.12M	236.50%5.14M	-318.25%-3.35M	-97.15%-6.15M
Effect of exchange rate changes	--12K	-319.33%-329K	-14.09%-510K	-88.12%96K	163.43%85K	--0	134.97%150K	-432.14%-447K	11,442.86%808K	47.45%-134K
End cash Position	-16.00%16.93M	-25.53%17.98M	-25.53%17.98M	-33.43%12.95M	-32.97%14.74M	-28.73%20.15M	-29.21%24.15M	-29.21%24.15M	-48.75%19.45M	-43.25%21.99M
Free cash flow	49.71%-1.55M	24.34%-12.81M	384.07%1.36M	-9.02%-3.49M	-1.21%-7.6M	46.47%-3.08M	-20.98%-16.93M	88.78%-477K	-794.69%-3.2M	-139.50%-7.51M
Currency Unit	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall